Tiopronin Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules
Available Strengths: 100 mg, 200 mg , 300 mg
Reference Brands: Thiola (USA), Mercaptamine (EU)
Category:
Nephrology
Tiopronin is available in Tablets, Capsules
and strengths such as 100 mg, 200 mg , 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tiopronin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tiopronin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tiopronin, marketed under the brand name Thiola, is a medication used to manage cystinuria, a rare genetic disorder that causes excessive cystine in the urine and leads to recurrent kidney stone formation. Tiopronin works by binding to cystine, forming a more soluble complex that reduces the risk of cystine crystallization and stone formation, helping to prevent kidney damage and associated complications.
The medication is indicated for patients weighing 20 kilograms (44 lb) and above with severe homozygous cystinuria who do not respond adequately to standard measures such as high fluid intake, urinary alkalinization, and dietary modifications. Tiopronin is used as part of a comprehensive treatment plan to control cystine excretion and maintain kidney function.
Administered orally, Tiopronin requires careful monitoring to ensure efficacy and safety. Side effects may include gastrointestinal disturbances, rash, or changes in liver function, making regular follow-up and laboratory testing important. By effectively reducing cystine precipitation, Tiopronin provides a valuable therapeutic option for patients with severe cystinuria, helping to decrease the frequency of kidney stone formation, improve quality of life, and support long-term renal health.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing